Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder
- PMID: 18573639
- PMCID: PMC2612126
- DOI: 10.1016/j.schres.2008.05.019
Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder
Abstract
Gender differences have been widely observed in the clinical presentation, psychosocial functioning and course of illness in first-episode and chronic patients suffering from schizophrenia. However, little is known about gender differences in the psychosis prodrome. This study investigated gender differences in symptoms, functioning and social support in individuals at ultra-high-risk for developing a psychotic disorder. Sixty-eight ultra-high-risk patients were assessed at baseline, and twenty-seven returned for follow-up assessments approximately 6 and 12 months later. Clinical symptoms and functioning were assessed by clinical interview; social support was measured using a self-report questionnaire. There were no gender differences in demographic variables, symptoms or functioning at baseline. Males were found to have significantly higher levels of negative symptoms and marginally lower levels of functioning when baseline and follow-up time points were considered collectively. Additionally, females reported higher levels of social support at baseline. Differences in negative symptoms were found to mediate differences in functioning between male and female patients. This study suggests that gender based differences in symptom presentation and functional outcome may predate conversion to psychosis. Follow-up studies should examine the relationship between symptoms, functioning and social support in this population.
Figures


Similar articles
-
The association between social anxiety and social functioning in first episode psychosis.Schizophr Res. 2005 Jul 15;76(2-3):287-92. doi: 10.1016/j.schres.2005.01.001. Schizophr Res. 2005. PMID: 15949660
-
Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.Schizophr Res. 2004 Apr 1;67(2-3):131-42. doi: 10.1016/S0920-9964(03)00192-0. Schizophr Res. 2004. PMID: 14984872
-
Premorbid adjustment in schizophrenia and schizoaffective disorder.Psychiatry Res. 2009 Feb 28;165(3):234-40. doi: 10.1016/j.psychres.2007.11.004. Epub 2009 Jan 21. Psychiatry Res. 2009. PMID: 19162333
-
[Duration of untreated psychosis: A state-of-the-art review and critical analysis].Encephale. 2016 Aug;42(4):361-6. doi: 10.1016/j.encep.2015.09.007. Epub 2016 May 6. Encephale. 2016. PMID: 27161262 Review. French.
-
[Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].Encephale. 2017 May;43(3):292-297. doi: 10.1016/j.encep.2017.01.005. Epub 2017 Mar 25. Encephale. 2017. PMID: 28347521 Review. French.
Cited by
-
Review of factors resulting in systemic biases in the screening, assessment, and treatment of individuals at clinical high-risk for psychosis in the United States.Front Psychiatry. 2023 Mar 13;14:1117022. doi: 10.3389/fpsyt.2023.1117022. eCollection 2023. Front Psychiatry. 2023. PMID: 36993932 Free PMC article. Review.
-
Demographic correlates of attenuated positive psychotic symptoms.Schizophr Res. 2015 Aug;166(1-3):31-6. doi: 10.1016/j.schres.2015.04.035. Epub 2015 May 18. Schizophr Res. 2015. PMID: 25999040 Free PMC article.
-
Effects of age and sex on clinical high-risk for psychosis in the community.World J Psychiatry. 2020 May 19;10(5):101-124. doi: 10.5498/wjp.v10.i5.101. eCollection 2020 May 19. World J Psychiatry. 2020. PMID: 32477906 Free PMC article.
-
Social support and adaptation to the disease in men and women with psoriasis.Arch Dermatol Res. 2012 Aug;304(6):421-32. doi: 10.1007/s00403-012-1235-3. Epub 2012 Mar 29. Arch Dermatol Res. 2012. PMID: 22456752 Free PMC article.
-
Sex steroids and schizophrenia.Rev Endocr Metab Disord. 2012 Sep;13(3):187-207. doi: 10.1007/s11154-011-9184-2. Rev Endocr Metab Disord. 2012. PMID: 21603930 Review.
References
-
- Angermeyer MC, Kühn L, Goldstein JM. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull. 1990;16(2):293–307. - PubMed
-
- Amminger GP, Leicester S, Yung AR, Phillips LJ, Berger GE, Francey SM, Yuen HP, McGorry PD. Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res. 2006;84(1):67–76. - PubMed
-
- Bardenstein KK, McGlashan TH. Gender differences in affective, schizoaffective, and schizophrenic disorders: A review. Schizophr Res. 1990;3(3):159–172. - PubMed
-
- Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome. Arch Gen Psychiatry. 1991;48(3):239–246. - PubMed
-
- Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse: a meta-analysis. Arch Gen Psychiatry. 1998;55(6):547–552. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical